Why This Matters for Your Career
Humanwell Pharmaceutical is hiring 2 roles related to this product
PIOGLITAZONE (pioglitazone hydrochloride) by Humanwell Pharmaceutical is action. Approved for type 2 diabetes mellitus in multiple clinical settings, type 2 diabetes mellitus.
Drug data last refreshed 1mo ago
action. Pioglitazone decreases insulin resistance in the periphery and in the liver resulting in increased insulin-dependent glucose disposal and decreased hepatic glucose output. Pioglitazone is not an insulin secretagogue. Pioglitazone is an agonist for peroxisome proliferator-activated…
Worked on PIOGLITAZONE at Humanwell Pharmaceutical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin
Effects of Pioglitazone in Calcific Aortic Valve Disease
Humanwell Pharmaceutical is hiring 2 roles related to this product